Stronger Together: Pfizer Highlights Newly Combined Oncology Portfolio

 
• By Jessica Merrill

The company showcased its expanded cancer drug pipeline two months after completing the acquisition of Seagen last year.

Pfizer sign
Pfizer held an investor day to highlight its oncology portfolio. • Source: Shutterstock

More from Anticancer

More from Therapy Areas